This announcement is a separate document:
H.U.グループホールディングス：富士レビオとベックマン・コールターがパートナーシップを拡大し、患者に優しい血液ベースの神経変性疾患診断薬を開発します
H U Group Holdings: Fujirebio and Beckman Coulter Expand Partnership to Develop Patient-Friendly, Blood-based Neurodegenerative Disease Diagnostics
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.